RT @eIMPAQc: 📢 New paper on the validity of PROMIS anxiety measures for cancer patients is out in @JPRO_ISOQOL ! It confirms PROMIS anxiety…
RT @eIMPAQc: 📢 New paper on the validity of PROMIS anxiety measures for cancer patients is out in @JPRO_ISOQOL ! It confirms PROMIS anxiety…
RT @eIMPAQc: 📢 New paper on the validity of PROMIS anxiety measures for cancer patients is out in @JPRO_ISOQOL ! It confirms PROMIS anxiety…
📢 New paper on the validity of PROMIS anxiety measures for cancer patients is out in @JPRO_ISOQOL ! It confirms PROMIS anxiety measures are equivalent, but not superior to, GAD-7 and HADS-A in an oncology sample @sylviedlambert1 @brainpanthet
Excited to see this out. Validation of PROMIS anxiety measures against structured clinical interview & legacy measures in oncology @JPRO_ISOQOL #nihpromis #healthmeasures
RT @JPRO_ISOQOL: Convergent and criterion validity of PROMIS anxiety measures relative to six legacy measures and a structured diagnostic i…
Convergent and criterion validity of PROMIS anxiety measures relative to six legacy measures and a structured diagnostic interview for anxiety in cancer patients https://t.co/9hmx9DKIic
Convergent and criterion validity of PROMIS anxiety measures relative to six legacy measures and a structured diagnostic interview for anxiety in cancer patients https://t.co/bfkNRnNfVl
Convergent and criterion validity of PROMIS anxiety measures relative to six legacy measures and a structured diagnostic interview for anxiety in cancer patients https://t.co/WVGB8CS0Vc https://t.co/PpyTulSDcS